Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1976 1
1979 1
1983 2
1984 1
1985 1
1987 2
1988 5
1989 1
1990 2
1991 2
1993 1
1994 2
1995 9
1996 8
1997 5
1998 5
1999 5
2000 4
2001 10
2002 7
2003 12
2004 9
2005 12
2006 14
2007 8
2008 14
2009 13
2010 6
2011 5
2012 10
2013 8
2014 10
2015 8
2016 6
2017 8
2018 4
2019 6
2020 1
2021 9
2022 11
Text availability
Article attribute
Article type
Publication date

Search Results

222 results
Results by year
Filters applied: . Clear all
Page 1
BNT162b2 mRNA COVID-19 vaccination in immunocompromised patients: A prospective cohort study.
Rahav G, Lustig Y, Lavee J, Ohad Benjamini, Magen H, Hod T, Noga Shem-Tov, Shmueli ES, Drorit Merkel, Ben-Ari Z, Halperin R, Indenbaum V, Olmer L, Huppert A, Mor E, Regev-Yochay G, Cohen C, Finesod AW, Levy I. Rahav G, et al. Among authors: halperin r. EClinicalMedicine. 2021 Nov;41:101158. doi: 10.1016/j.eclinm.2021.101158. Epub 2021 Oct 17. EClinicalMedicine. 2021. PMID: 34693234 Free PMC article.
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer.
Morris WJ, Tyldesley S, Rodda S, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J, Murray N. Morris WJ, et al. Among authors: halperin r. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):275-285. doi: 10.1016/j.ijrobp.2016.11.026. Epub 2016 Nov 24. Int J Radiat Oncol Biol Phys. 2017. PMID: 28262473 Clinical Trial.
ASCENDE-RT: An Analysis of Treatment-Related Morbidity for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost with a Dose-Escalated External Beam Boost for High- and Intermediate-Risk Prostate Cancer.
Rodda S, Tyldesley S, Morris WJ, Keyes M, Halperin R, Pai H, McKenzie M, Duncan G, Morton G, Hamm J, Murray N. Rodda S, et al. Among authors: halperin r. Int J Radiat Oncol Biol Phys. 2017 Jun 1;98(2):286-295. doi: 10.1016/j.ijrobp.2017.01.008. Epub 2017 Jan 6. Int J Radiat Oncol Biol Phys. 2017. PMID: 28433432 Clinical Trial.
Third dose of the BNT162b2 vaccine in heart transplant recipients: Immunogenicity and clinical experience.
Peled Y, Ram E, Lavee J, Segev A, Matezki S, Wieder-Finesod A, Halperin R, Mandelboim M, Indenbaum V, Levy I, Sternik L, Raanani E, Afek A, Kreiss Y, Lustig Y, Rahav G. Peled Y, et al. Among authors: halperin r. J Heart Lung Transplant. 2022 Feb;41(2):148-157. doi: 10.1016/j.healun.2021.08.010. Epub 2021 Aug 28. J Heart Lung Transplant. 2022. PMID: 34565682 Free PMC article.
Improved methods for RNAseq-based alternative splicing analysis.
Halperin RF, Hegde A, Lang JD, Raupach EA; C4RCD Research Group, Legendre C, Liang WS, LoRusso PM, Sekulic A, Sosman JA, Trent JM, Rangasamy S, Pirrotte P, Schork NJ. Halperin RF, et al. Sci Rep. 2021 May 24;11(1):10740. doi: 10.1038/s41598-021-89938-2. Sci Rep. 2021. PMID: 34031440 Free PMC article.
Genomic and Transcriptomic Analysis of Relapsed and Refractory Childhood Solid Tumors Reveals a Diverse Molecular Landscape and Mechanisms of Immune Evasion.
Byron SA, Hendricks WPD, Nagulapally AB, Kraveka JM, Ferguson WS, Brown VI, Eslin DE, Mitchell D, Cornelius A, Roberts W, Isakoff MS, Oesterheld JE, Wada RK, Rawwas J, Neville K, Zage PE, Harrod VL, Bergendahl G, VanSickle E, Dykema K, Bond J, Chou HC, Wei JS, Wen X, Reardon HV, Roos A, Nasser S, Izatt T, Enriquez D, Hegde AM, Cisneros F, Christofferson A, Turner B, Szelinger S, Keats JJ, Halperin RF, Khan J, Saulnier Sholler GL, Trent JM. Byron SA, et al. Among authors: halperin rf. Cancer Res. 2021 Dec 1;81(23):5818-5832. doi: 10.1158/0008-5472.CAN-21-1033. Epub 2021 Oct 5. Cancer Res. 2021. PMID: 34610968
[Adnexal masses: understanding and management].
Smorgick N, Schneider D, Pansky M, Herman A, Halperin R. Smorgick N, et al. Among authors: halperin r. Harefuah. 2008 Jan;147(1):49-52, 94. Harefuah. 2008. PMID: 18300624 Review. Hebrew.
Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
LoRusso PM, Sekulic A, Sosman JA, Liang WS, Carpten J, Craig DW, Solit DB, Bryce AH, Kiefer JA, Aldrich J, Nasser S, Halperin R, Byron SA, Pilat MJ, Boerner SA, Durecki D, Hendricks WPD, Enriquez D, Izatt T, Keats J, Legendre C, Markovic SN, Weise A, Naveed F, Schmidt J, Basu GD, Sekar S, Adkins J, Tassone E, Sivaprakasam K, Zismann V, Calvert VS, Petricoin EF, Fecher LA, Lao C, Eder JP, Vogelzang NJ, Perlmutter J, Gorman M, Manica B, Fox L, Schork N, Zelterman D, DeVeaux M, Joseph RW, Cowey CL, Trent JM. LoRusso PM, et al. Among authors: halperin r. PLoS One. 2021 Apr 7;16(4):e0248097. doi: 10.1371/journal.pone.0248097. eCollection 2021. PLoS One. 2021. PMID: 33826614 Free PMC article. Clinical Trial.
Employment outcomes for recent Canadian radiation oncology graduates.
Loewen SK, Halperin R, Perry G, McKenzie M, Vigneault E, Stuckless T, Brundage M. Loewen SK, et al. Among authors: halperin r. Curr Oncol. 2019 Aug;26(4):e510-e514. doi: 10.3747/co.26.4925. Epub 2019 Aug 1. Curr Oncol. 2019. PMID: 31548819 Free PMC article.
222 results